- Home
- CTXR vs RBOT Comparison
CTXR vs RBOT Comparison
Compare CTXR & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTXR | RBOT |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 17.9M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | CTXR | RBOT |
|---|---|---|
| Price | $0.84 | $1.98 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | $6.00 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 585.2K | 58.9K |
| Earning Date | 06-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.38 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $147.57 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $1.71 |
| 52 Week High | $2.38 | $13.75 |
Technical Indicators
Market Signals| Indicator | CTXR | RBOT |
|---|---|---|
| Relative Strength Index (RSI) | 55.02 | 45.38 |
| Support Level | $0.66 | $1.76 |
| Resistance Level | $0.97 | $2.41 |
| Average True Range (ATR) | 0.07 | 0.20 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 58.09 | 38.63 |
Price Performance
Historical ComparisonAbout CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.